InvestorsHub Logo
Followers 64
Posts 6681
Boards Moderated 2
Alias Born 02/07/2013

Re: None

Wednesday, 10/22/2014 9:07:11 PM

Wednesday, October 22, 2014 9:07:11 PM

Post# of 27557
Emergent to submit proposal for experimental Ebola drug

"The Ebola drug ZMapp is in experimental stages and is made in limited doses by San Diego-based Mapp Biopharmaceutical Inc. Havey said Emergent likely will partner with Mapp and plant-based manufacturers to produce the drug as part of its proposal.

Mapp has not yet conducted clinical tests in humans to determine its effectiveness, according to the federal health department, but ZMapp has been given to aid workers in West Africa. Havey said Mapp had started small trials on animals before the recent Ebola outbreak."

Be nice if...plant-based manufacturers such as Caliber Biotherapeutics..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News